Effectiveness Study of Zymar Versus Vigamox for Preoperative Sterilization of the Ocular Surface After Loading Dose

Status unconfirmed · Phase 4

Conditions studied: Eye Infection, Infection

In brief

The purpose of this study is to analyze the effect of Zymar and Vigamox on ocular surface bacteria. We believe that Zymar will eradicate more ocular surface bacteria than Vigamox.

Key facts

Study ID

NCT00347828

Run by

Ophthalmic Consultants of Boston

People needed

40

Starts

2006-06-01

Expected to finish

2006-06-01

Last updated by the study team

2006-07-04

Who can join

Age: 25 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female 25 years of age or older
• Informed consent
• Likely to complete the entire course of the study

You may not qualify if…

• Contraindications or known sensitivity to any component of the study medications
• A subject on oral or topical antibiotics
• A subject that has a condition (i.e. an uncontrolled systemic disease) or is in a situation which, in the investigator's opinion, may put the subject at significant risk, may confound the trial results, or may interfere significantly with the subject's participation in the trial.
• Monocular subjects
• Contact lens wearers
• Subjects who regularly take eyedrops other than preservative free artificial tears
• A subject with an eye infection

Where it is running

• Ophthalmic Consultants of Boston — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.